Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Total 13F shares
-
65,905,596
-
Share change
-
-721,915
-
Total reported value
-
$8,048,128,736
-
Put/Call ratio
-
21%
-
Price per share
-
$122.13
-
Number of holders
-
179
-
Value change
-
-$71,111,968
-
Number of buys
-
89
-
Number of sells
-
86
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q4 2022
As of 31 Dec 2022 Ascendis Pharma A/S - ADR (ASND) had 179 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 65,905,596 shares of stock of the company.
Largest 10 holders included RA CAPITAL MANAGEMENT, L.P., Artisan Partners Limited Partnership, FMR LLC, BAKER BROS. ADVISORS LP, PRICE T ROWE ASSOCIATES INC /MD/, JANUS HENDERSON GROUP PLC, WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, and T. Rowe Price Investment Management, Inc..
This table shows 182 institutional shareholders of the security as of 31 Dec 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.